Verheij-Hart, E.

steatosi genotype patient treatment hepatitis hepatitis c study virus group liver hepatitis c virus outcome body mass index genotype 3 response treatment outcome brosi liver steatosis journal fi brosis signi -3 group genotype 3 patients kg /m baseline level hepatitis c patients genotype 3 group serum infection ficant analysis ó 2006 hepatology baseline fi brosis stage hcv genotype 3 hcv-rna impact sahlgrenska university hospital fi nal outcome hcv infection hepatol reduction presence index author publishing compilation result weight blackwell university biopsy pretreatment 29–35 westin study groups genotype 3 infection hospital grade -3 genotypes treatment response cirrhosis -3 patients genotype 2 patients hepatic steatosis 12 weeks fi nding signi ficantly serum triglyceride levels therapy serum cholesterol levels resistance hepatocyte steatosis log-rank test factor kinetic signi ficant impact disease variable